Jung-ah Choi

585 total citations
22 papers, 255 citations indexed

About

Jung-ah Choi is a scholar working on Immunology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jung-ah Choi has authored 22 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Infectious Diseases and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jung-ah Choi's work include Influenza Virus Research Studies (4 papers), Advancements in Transdermal Drug Delivery (3 papers) and Immune Cell Function and Interaction (3 papers). Jung-ah Choi is often cited by papers focused on Influenza Virus Research Studies (4 papers), Advancements in Transdermal Drug Delivery (3 papers) and Immune Cell Function and Interaction (3 papers). Jung-ah Choi collaborates with scholars based in South Korea, United States and United Kingdom. Jung-ah Choi's co-authors include Manki Song, Jung‐Hwan Park, Eunji Yang, Sung‐Moo Park, In Su Cheon, Byoung-Shik Shim, Konrad Stadler, Young Ki Choi, Simon M. Cutting and Huynh A. Hong and has published in prestigious journals such as PLoS ONE, Journal of Virology and International Journal of Pharmaceutics.

In The Last Decade

Jung-ah Choi

19 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung-ah Choi South Korea 9 79 68 64 63 55 22 255
Sonsire Fernández-Castillo Cuba 11 84 1.1× 110 1.6× 42 0.7× 77 1.2× 76 1.4× 30 292
Kairat Tabynov Kazakhstan 10 76 1.0× 130 1.9× 23 0.4× 70 1.1× 73 1.3× 25 274
Ruchi R. Shah United States 4 144 1.8× 60 0.9× 28 0.4× 108 1.7× 44 0.8× 5 256
Thomas Parks United States 7 62 0.8× 74 1.1× 6 0.1× 165 2.6× 152 2.8× 13 452
Lindsey Galmin United States 9 139 1.8× 93 1.4× 8 0.1× 51 0.8× 80 1.5× 13 290
Jessica A. White United States 12 36 0.5× 154 2.3× 20 0.3× 62 1.0× 68 1.2× 25 292
Jingxian Zhou China 6 19 0.2× 24 0.4× 8 0.1× 81 1.3× 55 1.0× 13 231
Aisling M. Towell Ireland 7 25 0.3× 115 1.7× 7 0.1× 171 2.7× 20 0.4× 8 327
Sabine Nakowitsch Austria 11 100 1.3× 75 1.1× 23 0.4× 97 1.5× 153 2.8× 14 328
Ashley Webb United States 10 109 1.4× 186 2.7× 7 0.1× 62 1.0× 413 7.5× 11 535

Countries citing papers authored by Jung-ah Choi

Since Specialization
Citations

This map shows the geographic impact of Jung-ah Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung-ah Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung-ah Choi more than expected).

Fields of papers citing papers by Jung-ah Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung-ah Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung-ah Choi. The network helps show where Jung-ah Choi may publish in the future.

Co-authorship network of co-authors of Jung-ah Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Jung-ah Choi. A scholar is included among the top collaborators of Jung-ah Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung-ah Choi. Jung-ah Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seo, Sang Hwan, et al.. (2025). Enhanced replication of a hepatitis A virus vaccine strain via adaptation in Vero cells. Clinical and Experimental Vaccine Research. 14(1). 10–10.
2.
3.
Seo, Sang Hwan, et al.. (2025). Mouse strain-dependent neutralizing antibody responses to Zika virus vaccines. The Journal of Microbiology. 63(8). e2504005–e2504005. 1 indexed citations
4.
Park, Hee-Seon, et al.. (2023). Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits. Vaccine. 41(46). 6842–6851. 1 indexed citations
5.
Kim, Jong-Chan, et al.. (2023). Pharmaceutical and Immunological Evaluation of Cholera Toxin A1 Subunit as an Adjuvant of Hepatitis B Vaccine Microneedles. Pharmaceutical Research. 40(12). 3059–3071. 2 indexed citations
6.
Choi, Jung-ah & Jae‐Ouk Kim. (2022). Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies. The Journal of Microbiology. 60(3). 238–246. 9 indexed citations
7.
Pang, Yanghee, Oksoo Kim, Jung-ah Choi, et al.. (2021). Vitamin D deficiency and associated factors in south Korean childbearing women: a cross-sectional study. BMC Nursing. 20(1). 218–218. 6 indexed citations
8.
Yi, Kye Sook, Jung-ah Choi, Dong-Kyun Ryu, et al.. (2020). Broader neutralization of CT-P27 against influenza A subtypes by combining two human monoclonal antibodies. PLoS ONE. 15(7). e0236172–e0236172. 13 indexed citations
9.
Choi, Jung-ah, Jongchan Kim, Eunji Yang, et al.. (2020). Microneedles with dual release pattern for improved immunological efficacy of Hepatitis B vaccine. International Journal of Pharmaceutics. 591. 119928–119928. 41 indexed citations
10.
Nguyen, Thuy Trang, Jung-ah Choi, Eunji Yang, et al.. (2019). Skin immunization with third-generation hepatitis B surface antigen using microneedles. Vaccine. 37(40). 5954–5961. 29 indexed citations
11.
Shim, Byoung-Shik, In Su Cheon, Eugene Lee, et al.. (2018). Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain. Journal of Immunology Research. 2018. 1–11. 9 indexed citations
12.
Choi, Jung-ah, et al.. (2018). An Analysis of Research Trend and Task on Korean School Counseling teachers: Professional Counseling Teacher versus Career Counseling Teacher. 27(1). 71–107. 2 indexed citations
13.
Ko, Albert I., Inmoo Rhee, Jin‐Ah Park, et al.. (2017). Comparison of the adjuvanticity of two adjuvant formulations containing de-O-acylated lipooligosaccharide on Japanese encephalitis vaccine in mice. Archives of Pharmacal Research. 41(2). 219–228. 8 indexed citations
14.
Yang, Eunji, Yonggeun Cho, Jung-ah Choi, et al.. (2015). Protection of Mice Against Pandemic H1N1 Influenza Virus Challenge After Immunization with Baculovirus-Expressed Stabilizing Peptide Fusion Hemagglutinin Protein. Journal of Microbiology and Biotechnology. 25(2). 280–287. 2 indexed citations
15.
Choi, Jung-ah, et al.. (2015). Improvement of medical law regulations for telemedicine services. The journal of the convergence on culture technology. 1(2). 85–89. 1 indexed citations
16.
Kim, Hye Kwon, Jeong-Ki Kim, Jung-ah Choi, et al.. (2014). Preliminary study about sublingual administration of bacteria-expressed pandemic H1N1 influenza vaccine in miniature pigs. The Journal of Microbiology. 52(9). 794–800. 4 indexed citations
17.
Song, Manki, Huynh A. Hong, Jen-Min Huang, et al.. (2012). Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine. Vaccine. 30(22). 3266–3277. 78 indexed citations
19.
Choi, Jung-ah, Jong-Sug Park, Bum‐Soo Hahn, et al.. (2009). Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice. Immune Network. 9(6). 265–265. 12 indexed citations
20.
Choi, Jung-ah, et al.. (1998). Synthesis and antifungal evaluation of 6-(N-arylamino)-7-methylthio-5,8-quinolinediones. Archives of Pharmacal Research. 21(4). 440–444. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026